Matthew Maryniak
President,
FENIX Group International LLC
United States
Matthew is the President of FENIX Group International. He is a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006. Regular attendance at large and small CV/MET scientific meetings. Architect of novel methods for assessing market opportunities. Matthew's areas of expertise include market landscaping / thought leadership, life sciences consulting / business intelligence. Matthew regualrly contributes Diabetes therapy area leadership in insulin, incretin therapies, novel MOAs, and diabetes devices.
Sessions
-
18-Jun-2025252ABCI for the Biotech Journey: Applying Lessons from Pharma
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}